Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1111/bjh.13619

Type

Journal

Br J Haematol

Publication Date

05/2016

Volume

173

Pages

487 - 491

Keywords

DLBCL, R-CHOP, dose intensity, elderly, Age Factors, Aged, Aged, 80 and over, Antibodies, Monoclonal, Murine-Derived, Antineoplastic Combined Chemotherapy Protocols, Cohort Studies, Cyclophosphamide, Disease-Free Survival, Doxorubicin, Humans, Infections, Lymphoma, Large B-Cell, Diffuse, Prednisone, Retrospective Studies, Risk Factors, Rituximab, Survival Rate, Treatment Outcome, Vincristine